Variant report

Variant	esv1836167
Chromosome Location	chr12:1618365-1645257
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:796)
CpG islands
(count:734)
Chromatin interactive
region (count:24)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:796 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr12:1628548-1628571	HepG2	liver:	n/a	n/a
2	ATF2	chr12:1642413-1643425	GM12878	blood:	n/a	n/a
3	ATF2	chr12:1642828-1643462	GM12878	blood:	n/a	n/a
4	BACH1	chr12:1640441-1640668	H1-hESC	embryonic stem cell:	n/a	n/a
5	BACH1	chr12:1640890-1641157	H1-hESC	embryonic stem cell:	n/a	n/a
6	BACH1	chr12:1632875-1633009	H1-hESC	embryonic stem cell:	n/a	n/a
7	BATF	chr12:1642796-1643534	GM12878	blood:	n/a	chr12:1643476-1643485
8	BATF	chr12:1641235-1641637	GM12878	blood:	n/a	n/a
9	BCL11A	chr12:1642764-1643553	GM12878	blood:	n/a	chr12:1643330-1643343 chr12:1642976-1642985
10	BCL11A	chr12:1642852-1643145	GM12878	blood:	n/a	chr12:1642976-1642985
11	BCL3	chr12:1628296-1628851	A549	lung:	n/a	chr12:1628532-1628541
12	BCL3	chr12:1628282-1628867	A549	lung:	n/a	chr12:1628532-1628541
13	BCL3	chr12:1642795-1643212	GM12878	blood:	n/a	chr12:1642976-1642985
14	BCLAF1	chr12:1642384-1643518	GM12878	blood:	n/a	chr12:1643330-1643343 chr12:1642976-1642985
15	BCLAF1	chr12:1642685-1643512	GM12878	blood:	n/a	chr12:1643330-1643343 chr12:1642976-1642985
16	BHLHE40	chr12:1642470-1643462	GM12878	blood:	n/a	n/a
17	BHLHE40	chr12:1635197-1635315	K562	blood:	n/a	n/a
18	BHLHE40	chr12:1643909-1644356	GM12878	blood:	n/a	n/a
19	BHLHE40	chr12:1635096-1635410	GM12878	blood:	n/a	n/a
20	BHLHE40	chr12:1641321-1641606	GM12878	blood:	n/a	n/a
21	BHLHE40	chr12:1639049-1639239	GM12878	blood:	n/a	n/a
22	CCNT2	chr12:1640162-1640764	K562	blood:	n/a	chr12:1640439-1640448
23	CCNT2	chr12:1639395-1639806	K562	blood:	n/a	n/a
24	CEBPB	chr12:1642858-1643174	GM12878	blood:	n/a	n/a
25	CEBPB	chr12:1625807-1626388	IMR90	lung:	n/a	n/a
26	CEBPB	chr12:1628415-1628821	IMR90	lung:	n/a	n/a
27	CEBPB	chr12:1618373-1618530	A549	lung:	n/a	n/a
28	CEBPB	chr12:1625949-1626001	Hela-S3	cervix:	n/a	n/a
29	CEBPB	chr12:1633008-1633195	H1-hESC	embryonic stem cell:	n/a	n/a
30	CEBPB	chr12:1642729-1643375	GM12878	blood:	n/a	n/a
31	CEBPB	chr12:1625793-1626078	K562	blood:	n/a	n/a
32	CHD1	chr12:1640471-1640598	GM12878	blood:	n/a	n/a
33	CHD1	chr12:1639146-1639271	GM12878	blood:	n/a	n/a
34	CHD1	chr12:1642439-1643570	GM12878	blood:	n/a	n/a
35	CHD2	chr12:1643998-1644194	GM12878	blood:	n/a	n/a
36	CHD2	chr12:1641222-1641500	GM12878	blood:	n/a	n/a
37	CHD2	chr12:1642386-1643477	GM12878	blood:	n/a	n/a
38	CHD2	chr12:1632843-1633160	H1-hESC	embryonic stem cell:	n/a	n/a
39	CREB1	chr12:1628341-1628701	A549	lung:	n/a	n/a
40	CTCF	chr12:1626420-1626570	Caco-2	colon:	n/a	chr12:1626480-1626501 chr12:1626478-1626496 chr12:1626481-1626490 chr12:1626479-1626495 chr12:1626481-1626494
41	CTCF	chr12:1641166-1641252	GM12891	blood:	n/a	chr12:1641182-1641195
42	CTCF	chr12:1627520-1627670	HMEC	breast:	n/a	n/a
43	CTCF	chr12:1626700-1626850	GM12865	blood:	n/a	n/a
44	CTCF	chr12:1626380-1626530	GM12865	blood:	n/a	chr12:1626480-1626501 chr12:1626478-1626496 chr12:1626481-1626490 chr12:1626479-1626495 chr12:1626481-1626494
45	CTCF	chr12:1642560-1642710	GM12864	blood:	n/a	n/a
46	CTCF	chr12:1642580-1642730	HBMEC	blood vessel:	n/a	n/a
47	CTCF	chr12:1626400-1626550	GM12871	blood:	n/a	chr12:1626480-1626501 chr12:1626478-1626496 chr12:1626481-1626490 chr12:1626479-1626495 chr12:1626481-1626494
48	CTCF	chr12:1642160-1642310	HCPEpiC	choroid plexus:	n/a	n/a
49	CTCF	chr12:1626380-1626530	HRE	kidney:	n/a	chr12:1626480-1626501 chr12:1626478-1626496 chr12:1626481-1626490 chr12:1626479-1626495 chr12:1626481-1626494
50	CTCF	chr12:1642160-1642310	GM12864	blood:	n/a	n/a

(count:734 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:1640392-1640442	GM12892	blood:	n/a
2	chr12:1641924-1641974	HMEC	breast:	n/a
3	chr12:1640392-1640442	GM12892	blood:	n/a
4	chr12:1641924-1641974	HMEC	breast:	n/a
5	chr12:1641924-1641974	PrEC	prostate:	n/a
6	chr12:1642663-1642713	AG04450	lung:	fetal
7	chr12:1633258-1633308	Jurkat	blood:	n/a
8	chr12:1640392-1640442	SAEC	small airway:	n/a
9	chr12:1639534-1639584	GM12892	blood:	n/a
10	chr12:1637124-1637174	SKMC	muscle:	n/a
11	chr12:1640660-1640710	MCF10A-Er-Src	breast:	n/a
12	chr12:1640660-1640710	HepG2	liver:	n/a
13	chr12:1637124-1637174	SK-N-SH	brain:	n/a
14	chr12:1633258-1633308	GM06990	blood:	n/a
15	chr12:1640660-1640710	ProgFib	skin:	n/a
16	chr12:1642879-1642929	NHBE	bronchial:	n/a
17	chr12:1639534-1639584	HMEC	breast:	n/a
18	chr12:1642879-1642929	HepG2	liver:	n/a
19	chr12:1642663-1642713	HRE	kidney:	n/a
20	chr12:1637124-1637174	HepG2	liver:	n/a
21	chr12:1640660-1640710	SK-N-SH_RA	brain:	n/a
22	chr12:1635982-1636032	HRE	kidney:	n/a
23	chr12:1639527-1639577	NT2-D1	testis:	n/a
24	chr12:1640392-1640442	LNCaP	prostate:	n/a
25	chr12:1639527-1639577	ovcar-3	ovarian:	n/a
26	chr12:1640660-1640710	PANC-1	pancreas:	n/a
27	chr12:1635982-1636032	PANC-1	pancreas:	n/a
28	chr12:1635982-1636032	HL-60	blood:	n/a
29	chr12:1640392-1640442	HL-60	blood:	n/a
30	chr12:1640392-1640442	PFSK-1	brain:	n/a
31	chr12:1640660-1640710	A549	lung:	n/a
32	chr12:1640660-1640710	AG04450	lung:	fetal
33	chr12:1642879-1642929	SKMC	muscle:	n/a
34	chr12:1639034-1639084	GM12892	blood:	n/a
35	chr12:1637124-1637174	HCT-116	colon:	n/a
36	chr12:1639534-1639584	PrEC	prostate:	n/a
37	chr12:1641924-1641974	A549	lung:	n/a
38	chr12:1628620-1628670	HUVEC	blood vessel:	n/a
39	chr12:1642663-1642713	HepG2	liver:	n/a
40	chr12:1642663-1642713	Hepatocyte	liver:	n/a
41	chr12:1640392-1640442	GM12891	blood:	n/a
42	chr12:1642663-1642713	ovcar-3	ovarian:	n/a
43	chr12:1628620-1628670	HIPEpiC	eye:	n/a
44	chr12:1641924-1641974	SAEC	small airway:	n/a
45	chr12:1637124-1637174	HEK293	kidney:	embryo
46	chr12:1633258-1633308	SK-N-SH	brain:	n/a
47	chr12:1637124-1637174	LNCaP	prostate:	n/a
48	chr12:1639527-1639577	BJ	skin:	n/a
49	chr12:1628620-1628670	ProgFib	skin:	n/a
50	chr12:1639527-1639577	RPTEC	kidney:	n/a

(count:24 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr12:1626153..1629399-chr12:1683454..1686746,3	MCF-7	breast:
2	chr12:1226666..1228780-chr12:1626005..1628648,2	MCF-7	breast:
3	chr12:1615017..1617424-chr12:1628113..1630003,2	MCF-7	breast:
4	chr12:1437851..1440138-chr12:1641572..1643434,2	K562	blood:
5	chr12:1627927..1629732-chr12:1638277..1639813,2	K562	blood:
6	chr12:1635757..1638197-chr12:1659223..1662121,2	K562	blood:
7	chr12:1629697..1630429-chr15:40937161..40938110,2	MCF-7	breast:
8	chr12:1608089..1610158-chr12:1624609..1627312,2	K562	blood:
9	chr12:1631412..1633755-chr12:1644616..1647066,2	K562	blood:
10	chr12:1632492..1634804-chr12:1681933..1684752,2	K562	blood:
11	chr12:1626921..1630129-chr12:1639679..1644833,6	MCF-7	breast:
12	chr12:1626725..1629627-chr12:1683737..1685681,2	MCF-7	breast:
13	chr12:1642084..1645971-chr12:1702065..1704505,3	K562	blood:
14	chr12:1545095..1547287-chr12:1641789..1644190,2	K562	blood:
15	chr12:1627927..1631783-chr12:1637016..1640816,5	K562	blood:
16	chr12:1607941..1609659-chr12:1618774..1621179,2	K562	blood:
17	chr12:1626245..1629061-chr12:1642130..1644083,2	MCF-7	breast:
18	chr12:1627443..1629034-chr12:1702544..1704207,2	MCF-7	breast:
19	chr12:1626245..1629061-chr12:1642130..1644083,2	MCF-7	breast:
20	chr12:1630597..1633129-chr12:1648512..1650359,2	MCF-7	breast:
21	chr12:1643386..1645620-chr12:1647542..1650042,3	K562	blood:
22	chr12:1611483..1613501-chr12:1625253..1627123,2	K562	blood:
23	chr12:1631412..1633755-chr12:1644616..1647066,2	K562	blood:
24	chr12:1645246..1648845-chr12:1650477..1653532,3	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-FBXL14-4	chr12:1634111-1634529	l_580_chr12:1634110-1648432_liver
2	lnc-FBXL14-4	chr12:1642645-1642816	l_580_chr12:1634110-1648432_liver

No data

Variant related genes	Relation type
WNT5B	TF binding region
LINC00942	TF binding region
WNT5B	CpG island
LINC00942	CpG island
ENSG00000171823	chromatin interactions
ENSG00000249628	chromatin interactions
ENSG00000111186	chromatin interactions

Extended variants
information (count: 1217 )
Associated
traits (count: 83 )

Variant overlapped rSNPs/rCNVs (count:1217 , 50 per page) page: 1 2 3 4 5 6 7 ... 25

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4238029	chr12:1618365-1618366	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs564676110	chr12:1618374-1618375	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs548673014	chr12:1618383-1618384	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs78287835	chr12:1618384-1618385	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs73043023	chr12:1618390-1618391	Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs190370591	chr12:1618407-1618408	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs182626355	chr12:1618492-1618493	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs147011066	chr12:1618496-1618497	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs570650490	chr12:1618498-1618499	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs548071169	chr12:1618506-1618507	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs4766380	chr12:1618513-1618514	Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
12	rs552730895	chr12:1618521-1618522	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs201373261	chr12:1618538-1618539	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs370055525	chr12:1618643-1618644	Weak transcription Enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs567888672	chr12:1618698-1618699	Weak transcription Enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs80272719	chr12:1618717-1618718	Weak transcription Enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs113137236	chr12:1618732-1618733	Weak transcription Enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs141293763	chr12:1618745-1618746	Weak transcription Enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs545480175	chr12:1618757-1618758	Weak transcription Enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs61912190	chr12:1618758-1618759	Weak transcription Enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs7975391	chr12:1618780-1618781	Weak transcription Enhancers Strong transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs7956995	chr12:1618820-1618821	Enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs117864887	chr12:1618830-1618831	Enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs560111409	chr12:1618855-1618856	Enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs530282433	chr12:1618875-1618876	Enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs146961965	chr12:1618917-1618918	Enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs563584309	chr12:1618967-1618968	Enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs77306742	chr12:1618974-1618975	Enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs137985038	chr12:1618975-1618976	Enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs11061798	chr12:1618985-1618986	Enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs555620676	chr12:1619004-1619005	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs146946727	chr12:1619086-1619087	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs10848502	chr12:1619118-1619119	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs568025692	chr12:1619136-1619137	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs77096321	chr12:1619165-1619166	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs557168370	chr12:1619180-1619181	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs189872428	chr12:1619184-1619185	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs539554281	chr12:1619215-1619216	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs11061799	chr12:1619220-1619221	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs182194522	chr12:1619265-1619266	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs149039937	chr12:1619281-1619282	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs10848503	chr12:1619300-1619301	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs575212999	chr12:1619347-1619348	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs10848504	chr12:1619377-1619378	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs61515136	chr12:1619398-1619399	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs550565864	chr12:1619401-1619402	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs563945291	chr12:1619405-1619406	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs544721538	chr12:1619413-1619414	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs149424713	chr12:1619432-1619433	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs10773950	chr12:1619440-1619441	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:83)

Disease	PMID	Source
Myelofibrosis	22110671	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Glaucoma	21310917	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Malignant peripheral nerve sheath tumor	19844265	CNVD
Squamous cell cancer	19607727	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Mental retardation	17847001	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
abnormal development	18461090	CNVD
Ovarian cancer	20844748	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Medulloblastoma	16968546	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Breast cancer	22032731	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Prostate cancer	21965145	CNVD
Acute myeloid leukemia	16864856	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Disorders of sex development	21048976	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Prostate cancer	19156837	CNVD
Emphysema	19352772	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Malignant germ cell tumour	17285132	CNVD
Melanoma	18172304	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21509527	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21785460	CNVD
Ovarian cancer	21720365	CNVD
Myelodysplastic syndrome	21251322	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Schizophrenia	23813976	CNVD
Cancer	20164919	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Melanoma	20877625	CNVD

Chromatin state (count:1006 , 50 per page) page: 1 2 3 4 5 6 7 ... 21

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:1608800-1618600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
2	chr12:1611600-1618800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
3	chr12:1612200-1626000	Weak transcription	Muscle Satellite Cultured Cells	--
4	chr12:1612800-1621200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
5	chr12:1614200-1626200	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
6	chr12:1614600-1618600	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
7	chr12:1615600-1618600	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
8	chr12:1618600-1618800	Bivalent Enhancer	Fetal Kidney	kidney
9	chr12:1618600-1619000	Strong transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
10	chr12:1618600-1619400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
11	chr12:1618600-1619600	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
12	chr12:1618600-1619600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
13	chr12:1618600-1619800	Enhancers	Fetal Muscle Leg	muscle
14	chr12:1618600-1620400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
15	chr12:1618800-1619200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
16	chr12:1618800-1619400	Enhancers	Fetal Kidney	kidney
17	chr12:1618800-1619800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
18	chr12:1619000-1619200	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
19	chr12:1619000-1619600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
20	chr12:1619000-1619800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
21	chr12:1619000-1626000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
22	chr12:1619200-1620000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
23	chr12:1619200-1620200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
24	chr12:1619600-1626400	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
25	chr12:1621400-1626000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
26	chr12:1624000-1624200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
27	chr12:1624000-1624200	ZNF genes & repeats	HSMM	muscle
28	chr12:1624200-1626600	Weak transcription	HSMM	muscle
29	chr12:1625600-1626400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
30	chr12:1625800-1626400	Enhancers	NHEK	skin
31	chr12:1626000-1626400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
32	chr12:1626000-1626400	Enhancers	HMEC	breast
33	chr12:1626000-1626600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
34	chr12:1626000-1627400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
35	chr12:1626000-1628000	Enhancers	Muscle Satellite Cultured Cells	--
36	chr12:1626000-1629400	Enhancers	NHDF-Ad	bronchial
37	chr12:1626200-1626400	Enhancers	Ovary	ovary
38	chr12:1626200-1626400	Enhancers	Osteobl	bone
39	chr12:1626200-1627200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
40	chr12:1626200-1627200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
41	chr12:1626200-1627800	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
42	chr12:1626400-1626600	Flanking Active TSS	NHEK	skin
43	chr12:1626400-1626800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
44	chr12:1626400-1626800	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
45	chr12:1626400-1626800	Flanking Active TSS	Osteobl	bone
46	chr12:1626400-1627000	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
47	chr12:1626400-1627000	Enhancers	NH-A	brain
48	chr12:1626400-1627400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
49	chr12:1626400-1628000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
50	chr12:1626400-1629000	Flanking Active TSS	HMEC	breast

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links